ArticleHypertension (Dallas, Tex. : 1979)2017

Preclinical and Early Clinical Profile of a Highly Selective and Potent Oral Inhibitor of Aldosterone Synthase (CYP11B2).

Katrijn Bogman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.